Ex-vivo Expanded γδ T-lymphocytes (OmnImmune®) in Patients With Acute Myeloid Leukaemia (AML)
Clinical trial NCT03790072 · COMPLETED
Trial details
- NCT number
- NCT03790072
- Sponsor
- TC Biopharm
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-27
- Primary completion
- 2021-03-26
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.